It occurs in patients with underlying disease which prevents normal response to infection, e. g. chronic leukaemia. Hodgkln's disease, cystic fibrosis, and patients on steroid therapy.

Which is precisely what happens in the case of chronic myelogenous leukaemia.

Two other studies, meanwhile, confirmed that a similar approach to chronic myelogenous leukaemia continues to bear fruit.